
The Double Helix, Spring 2022
Spring 2022 issue of quarterly NFID eNewsletter covering:
- The impacts of COVID-19 on vaccine research
- 2022 Annual Conference on Vaccinology Research (Online)
- Respiratory syncytial virus (RSV)
- Influenza (flu)
- Partner News
- More …
Message From Headquarters
COVID-19 has had an impact on all of us, both personally and professionally—including the focus of the Annual Conference on Vaccinology Research, which the National Foundation for Infectious Diseases (NFID) has hosted for more than 25 years. During the 2022 online conference next month, leading experts will explore the future of vaccinology research, addressing scientific challenges as well as the global threat of vaccine hesitancy. I hope to ‘see’ many of you there. COVID-19 experiences have taught us much about developing more effective vaccines, and some of these lessons may apply to respiratory syncytial virus (RSV) …
Related Posts

The Double Helix, Fall 2023
Fall 2023 issue of quarterly NFID eNewsletter covering: NFID National Survey: Attitudes about Respiratory Diseases 2023 Annual News Conference Online Clinical Vaccinology Course 50th Anniversary…

The Double Helix, Summer 2023
Summer 2023 issue of quarterly NFID eNewsletter covering: NFID 50th Anniversary New and Improved NFID Website Flu Awareness Night at Washington Nationals NFID 50th Anniversary…

The Double Helix, Spring 2023
Spring 2023 issue of quarterly NFID eNewsletter covering: NFID 50th Anniversary Reducing Health Disparities 2023 Annual Conference on Vaccinology Research Partner Spotlight NFID Resources (Webinars,…